Data / Form D filings / Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc.: Form D filings
Vaneltix Pharma, Inc., a pharmaceuticals company in New Brunswick, NJ, filed 7 Form D notices with the SEC between 2013 and 2024. The latest, on January 24, 2024, reports $1 million sold of a $5 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 317 GEORGE STREET, SUITE 400, New Brunswick, NJ, 08901
- Phone
- (732) 354-3217
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 932352
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 24, 2024 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 6 | Dec 12, 2023 | sec.gov |
| Nov 20, 2020 | New notice | $3,021,843 | $3,021,843 | 32 | Oct 21, 2020 | sec.gov | |
| Feb 7, 2018 | New notice | $1,377,000 | $1,377,000 | 22 | Jan 26, 2018 | sec.gov | |
| Apr 13, 2017 | New notice | $15,000,000 | $500,000 | $14,500,000 | 5 | Mar 30, 2017 | sec.gov |
| Jul 14, 2015 | New notice | $12,365,759 | $300,000 | $12,065,759 | 1 | Jul 1, 2015 | sec.gov |
| Oct 4, 2013 | Amendment | $856,000 | $856,000 | 17 | Jul 3, 2013 | sec.gov | |
| Jul 19, 2013 | New notice | $1,000,000 | $750,000 | $250,000 | 12 | Jul 3, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Vickery | Executive Officer, Director | |
| Carlo Lowell Di Fonzo | Director | |
| C. Lowell Parsons | Director | |
| Robert Lowell Evans | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vaneltix Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.